President of Valeant Europe sold ALL 10,000 shares of his stock on June 4, 2014
If the very head of Valeant Europe thinks their stock is overvalued and wants to get out, don't you think you should too? He is at the top of the inside and now currently owns zero shares.
Why should Allergan give up their strong/consistent/proven track record of success (that isn't over inflated) leadership team for Valeant's revolving door of leadership? Aside from Pearson, even Valeant's leaders know that Valeant's busines model and company culture are abysmal and not a recipe for success, and thus leave.